- Home
- / Bridge Biotherapeutics
Bridge Biotherapeutics
Stock Price
₩4.6 K
2024-10-29
Market Capitalization
₩212.1 B
2024-10-29
Revenue
₩2.2 M
FY, 2024
Bridge Biotherapeutics Summary
Company Summary
- Overview
- Bridge Biotherapeutics is a company that specializes in the research and development of drugs. Its product pipeline focuses on medications for the treatment of respiratory diseases, inflammation, and oncology.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- Seongnam-si, KR | view all locations
- Website
- http://bridgebiorx.com
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
3 locations detected
Seongnam-si, Gyeonggi-do HQ
Korea (Republic of)
303, c ’ s tower, 255 Pangyo-ro, Sampyeong-dong, Bundang-gu
Germantown, MD
United States
12410 Milestone Center Dr
Shanghai Shi
China
4560 Jinke Rd, Pudong Xinqu
Bridge Biotherapeutics Financials
Summary Financials
- Gross profit (Q3, 2025)
- ₩57.8M
- Net income (Q3, 2025)
- (₩3.5B)
- Cash (Q3, 2025)
- ₩21.6B
- EBIT (Q3, 2025)
- (₩3.4B)
- Enterprise value
- $195.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026